X
<

Monsanto Reports 4Q17 Earnings: Stock Unchanged

PART:
1 2 3 4 5 6
Monsanto Reports 4Q17 Earnings: Stock Unchanged PART 1 OF 6

Monsanto Reports 4Q17 Earnings: Stock Unchanged

Monsanto’s earnings

On October 4, 2017, Monsanto (MON) reported its fiscal 4Q17 and fiscal 2017 earnings. It delivered EPS (earnings per share) of $0.05, which was better than a loss of $0.44 in the corresponding quarter a year ago. For fiscal 2017, the company reported EPS of $5.09, which rose from $2.99 in fiscal 2016.

With the anticipation of completing a merger with Bayer next year, Monsanto’s management said this may be its final full-year earnings call as Monsanto.

Monsanto Reports 4Q17 Earnings: Stock Unchanged

Interested in MON? Don't miss the next report.

Receive e-mail alerts for new research on MON

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

How the market reacted

Monsanto’s ongoing EPS rose year-over-year from $0.07 to $0.20 in fiscal 4Q17, and for fiscal 2017, it rose year-over-year from $4.48 to $5.50. Its ongoing EPS was adjusted to exclude items that Monsanto doesn’t believe are part of its ongoing business.

After it released its fiscal 4Q17 earnings, MON stock ended almost flat at $119.75, which was down 6 basis points from the previous day’s close.

During the day, Syngenta (SYT) also ended almost flat. However, FMC (FMC) rose 71 basis points, and DowDuPont (DWDP) rose 16 basis points during the day. Over the same period, the S&P 500 Index (SPY) rose slightly by 5 basis points.

Series overview

In this earnings overview series, we’ll look at some of the key metrics for Monsanto’s 4Q17 earnings results. We’ll also see what management’s outlook is for the company and provide an update on the timeline for Monsanto’s merger with Bayer.

First, let’s look at Monsanto’s sales by segments.

X

Please select a profession that best describes you: